12/18/2025Leadingtac Raises Over CNY 200M in Series B to Advance Targeted Prote...

12/18/2025Rona Advances Dual-Targeting siRNA RN5681 Into Clinical Development

12/18/2025Hansoh Highlights Early Clinical Data for B7-H3 ADC Risvutatug Rezetec...

12/18/2025HUTCHMED Initiates Global Clinical Development of FIC ATTC Candidate H...

12/18/2025China Grants First Global Approval to Cytokinetics' Cardiomyopathy Dru...

12/18/2025CSL Elevates China to Core Global Strategic Market

12/18/2025Atom Thera Advances Anti-Inflammatory Pipeline With FDA Clearance for ...

12/18/2025Sanofi's Aficamten Wins China Approval for Obstructive Hypertrophic Ca...

12/18/2025Phil Rivers Raises CNY 100M in Series A1 to Advance Digital Twin–Dr...

12/18/2025Byrtna Secures Angel+ Financing to Advance Circular mRNA In Vivo CAR-T...

12/18/2025Valink and Nona Form Strategic Alliance to Accelerate Novel Biologics...

12/17/2025China Launches Pilot Program for Classified Management of Imported Foo...

12/17/2025CDE Solicits Comments on Draft Guidelines for Generic Ophthalmic Eye ...

12/17/2025China Opens Consultation on First ICH M13A Low-Risk Formulation List f...

12/17/2025GE HealthCare Opens New R&D Center in Tianjin

12/17/2025China Moves to Prosecute Former Traditional Medicine Regulator in Brib...

12/17/2025Ocgene Raises $30M Series B to Advance Global Mid-Stage Trials of Opht...

12/17/2025Allin Raises ~$50M in Series A+ to Advance Next-Gen ADC and Multispec...

12/17/2025BMS Expands Antibody Pipeline Thru Global Collaboration With Harbour B...

12/17/2025Hansoh and Glenmark Strike Multi-Regional Licensing Deal for EGFR Inhi...

12/16/2025GeneScience Signs Up to $1.37B Global Licensing Deal for TSHR Antibody...

12/16/2025D3 Bio Raises $108M Series B to Advance Global Phase III Program for ...

12/16/2025China Approves Genzyme's Fenthosilan Sodium Injection

12/16/2025Fosun Moves to Acquire Maker of Controversial Alzheimer's Drug

12/16/2025Western Gene Therapy Developers Look to China for Faster, Lower-Cost C...

12/16/2025InnoCare's Orelabrutinib Hits Primary Endpoint in Phase 2b Lupus Trial...

12/15/2025CDE Solicits Comments on First Batch of ICH M13A Low-Risk Formulation ...

12/15/2025CDE Seeks Comments on Draft Technical Guidelines for Generic Ophthalmi...

12/15/2025KYinno Raises ~CNY 250M in Series B to Advance Multispecific Antibod...

12/15/2025Qilu Advances GSPT1 Degrader ADC Program, PCT Patent Reveals

Page:1/59 Total number of articles:1743: [First][<<] [1] [2] [3] [4] [5] [>>] [End]